Why the study?
Does targeted next-generation sequencing identify novel gene-phenotype associations in patients with severe cardiomyopathies?
Population
38 unrelated patients with severe phenotypes and family history of cardiomyopathy and/or sudden death
Design
Cohort
Authors
Loading...
Expands the mutational spectrum of severe cardiomyopathies but should not yet alter routine genetic testing protocols.
Does targeted next-generation sequencing identify novel gene-phenotype associations in patients with severe cardiomyopathies?
Targeted next-generation sequencing expands the mutational spectrum and identifies novel gene-phenotype associations in patients with severe cardiomyopathies.
Forleo et al. (2017) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: